Delivery Order SPE2DB20D1004-SPE2DB24FG5U6

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,740.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Carvedilol ER 80 mg capsules. It is a Firm Fixed Price contract with a period of performance through February 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $9,843.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 80 mg capsules over a period ending on September 26, 2024. The contract is a Delivery Order under a Firm Fixed Price type, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,796.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Carvedilol ER 10 mg capsules and has an ultimate completion date of November 21, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,617.82 firm fixed-price delivery order is for the supply of Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,950.94, is for the delivery of Carvedilol ER 80 mg capsules. It is a firm fixed-price delivery order contract with an ultimate completion date of August 28, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 80 mg capsules. The firm-fixed-price delivery order, valued at $14,648.38, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $70,541.04 fixed-price delivery order is for Carvedilol ER 80 mg Capsules, which are used to treat cardiovascular conditions. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.54, is a delivery order for the supply of 80 mg Carvedilol ER capsules. The contract has a firm fixed price and an ultimate completion date of January 3, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,605.74 firm fixed-price delivery order covers the supply of Carvedilol ER 80 mg capsules to support military healthcare programs. The contract has an ultimate completion date of August 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award, valued at $87,112.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 10 mg capsules in 30-count packages and has an ultimate completion date of August 12, 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG5U6
    Delivery Order

This federal contract award, valued at $3,848.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 80 mg capsules and has an ultimate completion date of August 2, 2024.

The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:08 AM